6.4 Single-Use Devices, Outsourced Reprocessing, & IFU Review

CBIC Associate Infection Prevention and Control a-IPC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 About the CBIC a-IPC Certification 1.2 Exam Format, Scoring, & Logistics 1.3 Effective Study Strategies & Preparation Plan

2 Chapter 2: Processes to Identify Infectious Diseases

2.1 Chain of Infection & Pathogen Characteristics 2.2 Diagnostic & Laboratory Testing in IPC 2.3 Identifying Healthcare-Associated Infection Syndromes 2.4 Specimen Collection, Handling, Storage, & Transport 2.5 Colonization, Infection, Contamination, & Pseudo-Infection 2.6 Prophylactic, Empiric, & Therapeutic Antimicrobial Use 2.7 Host Risk Factors & Emerging Infectious Disease Threats

3 Chapter 3: Surveillance and Epidemiologic Investigation

3.1 Surveillance Methods & Program Design 3.2 Epidemiological Calculations & Rate Metrics 3.3 Outbreak Investigation Protocols & Epidemic Curves 3.4 NHSN Definitions & Standardized Infection Ratios (SIR) 3.5 Descriptive Statistics & Presenting Surveillance Data 3.6 Surveillance Across the Care Continuum 3.7 Notifiable Disease Reporting, Data Sources, & Registries 3.8 Data Validation & Surveillance Program Evaluation 3.9 Outbreak Control Measures, Environmental Sampling, & Reporting

4 Chapter 4: Preventing and Controlling Transmission

4.1 Standard Precautions & Hand Hygiene Guidelines 4.2 Transmission-Based Precautions & Isolation Protocols 4.3 PPE Selection, Donning, Doffing, & Safety 4.4 Safe Injection Practices & Medication Preparation 4.5 Patient-Care Equipment & Point-of-Care Device Handling 4.6 Emergency Preparedness & the Infection Preventionist's Disaster Role 4.7 Bioterrorism, Special Pathogens, & Community Response Planning

5 Chapter 5: Environment of Care

5.1 Environmental Cleaning & Surface Disinfection 5.2 Water Utilities, Air Handling, & Building Systems 5.3 Construction, Renovation, & Infection Control Risk Assessment (ICRA) 5.4 Laundry, Linen, Waste Management, & Food Safety 5.5 Product Recalls, Supply Chain Monitoring, & Device Incident Reporting

6 Chapter 6: Cleaning, Disinfection, and Sterilization of Medical Devices

6.1 Spaulding Classification System 6.2 Reprocessing Steps & High-Level Disinfection (HLD) 6.3 Sterilization Methods, Monitoring, & Quality Assurance 6.4 Single-Use Devices, Outsourced Reprocessing, & IFU Review 6.5 Reprocessing Failure Investigation & Patient Notification

7 Chapter 7: Employee and Occupational Health

7.1 Occupational Exposures & Post-Exposure Prophylaxis 7.2 Healthcare Personnel Immunizations & Screening 7.3 Work Restrictions & Fit-for-Duty Evaluations 7.4 Sharps Injury Prevention, Product Sensitivities, & Alternatives

8 Chapter 8: Management, Communication, and Antimicrobial Stewardship

8.1 IPC Program Governance, Policies, & Accreditation 8.2 Interdisciplinary Collaboration & Crisis Communication 8.3 Antimicrobial Stewardship Principles & Interventions 8.4 Chain of Command, Resource Advocacy, & the Business Case

9 Chapter 9: Education, Research, and Performance Improvement

9.1 Adult Learning Principles & Staff Education 9.2 Quality Improvement Models & Implementation Science 9.3 Critical Appraisal of Infection Prevention Literature

6.4 Single-Use Devices, Outsourced Reprocessing, & IFU Review

Key Takeaways Explain This Topic AI

A hospital may not reprocess single-use devices in-house unless it registers with the FDA as a manufacturer and meets all manufacturer requirements including premarket submission and quality system regulation.

The manufacturer's instructions for use are the legal and regulatory standard for reprocessing, and conflicts between device, detergent, and sterilizer instructions must be resolved with the manufacturers rather than at the bedside.

Reprocessability must be evaluated before purchase, because a device requiring a cycle, brush, or drying time the facility cannot provide becomes an unusable or unsafe purchase.

Loaner and consignment instruments must arrive with sufficient lead time and complete instructions, and must be decontaminated and inspected on arrival even when labeled sterile.

Immediate use steam sterilization is reserved for genuine emergencies, must never be used for implants except in documented emergencies, and must never compensate for inadequate instrument inventory.

Last updated: August 2026

6.4 Single-Use Devices, Outsourced Reprocessing, & IFU Review

Quick Answer: A device labeled single-use may not be reprocessed by the hospital unless the hospital registers with FDA as a manufacturer . Commercially reprocessed single-use devices are legal because third-party reprocessors are held to full manufacturer requirements. The manufacturer's instructions for use (IFU) are the standard — and must be reviewed before purchase , not after a device arrives.

The blueprint asks candidates to assist in reviewing product use and reprocessing requirements , naming single-use, on-site, and outsourced reprocessing. These are procurement and contracting decisions that determine whether frontline reprocessing can succeed at all.

Single-Use Devices

A single-use device (SUD) is labeled by its manufacturer for use on one patient during one procedure. Common examples include biopsy forceps, sphincterotomes, many electrophysiology catheters, laparoscopic shears, and pulse oximeter probes.

The regulatory position

Actor May reprocess an SUD? Requirements
Original manufacturer Yes, if validated and labeled for it Standard manufacturer obligations

Third-party commercial reprocessor Yes Registered with FDA as a manufacturer : premarket submission (510(k) where required), Quality System Regulation , validated cleaning and sterilization, adverse-event reporting, labeling as "reprocessed"

Hospital, in-house Only if it registers as a manufacturer and meets every requirement above In practice, effectively no

Since FDA's 2000 guidance, reprocessing SUDs has been regulated identically to original manufacture. Commercially reprocessed SUDs from a registered reprocessor are a legitimate, FDA-cleared cost and sustainability strategy; informal in-house reuse is not . The distinction that gets facilities into trouble is quietly re-sterilizing a single-use item because it "looks fine" and inventory is short.

Exam Tip: The correct answer to "the facility wants to reuse single-use devices to reduce cost" is to contract with an FDA-registered third-party reprocessor , not to reprocess in-house and not to reuse without processing.

Instructions for Use: The Governing Document

The IFU is not advisory. It is the validated process, and departing from it invalidates the manufacturer's claims, voids warranties, and creates regulatory and liability exposure.

What the IFU must specify
Point-of-use treatment and maximum delay before cleaning
Disassembly steps
Detergent type, concentration, temperature, and soak time
Brush sizes and channel cleaning specifics
Rinse water quality (utility, purified, or sterile)
Compatible disinfectants and disinfectants that must not be used
Sterilization modality, cycle type, temperature, exposure time, and dry time
Number of validated reprocessing cycles, where limited
Inspection and functional testing criteria
The IFU conflict problem

A single tray can involve three or four IFUs — device, container, detergent, sterilizer — that do not agree. A device may require a 4-minute dynamic-air-removal cycle at 132°C with a 30-minute dry time, while the rigid container is validated for a different dry time and the facility's sterilizer offers neither cycle.

These conflicts must be resolved in writing with the manufacturers before the device is used , and the resolution must be documented. They are never resolved by a technician choosing the closest available cycle.

Reviewing before purchase

Infection prevention should be a standing member of the value analysis / product standardization committee , and should ask before any purchase:

Can we physically perform this reprocessing — the brushes, the cycle, the drying, the space?

Do we have the required sterilizer cycle and validated container?

What is the turnaround time , and does our inventory support it without pressure to shortcut?

Are test strips, leak testers, borescopes or other verification tools required and available?

Is training required, and who provides it?

Is the IFU complete and in English , and is a current copy accessible in the reprocessing area?

Does the device have known reprocessing design problems (complex lumens, elevator mechanisms, hinged joints)?

A device that cannot be reprocessed correctly at this facility should not be purchased. That decision is far cheaper before the contract than after an outbreak.

Outsourced Reprocessing

When reprocessing is contracted out, the facility retains accountability for the outcome. The contract and oversight must address:

Element Requirement

Vendor qualification Documented validated processes, personnel certification, quality monitoring; on-site audit at defined intervals

Transport of contaminated devices Leak-proof, biohazard-labeled containment; defined time limits so bioburden does not dry

Transport of processed devices Protection of package integrity and sterility during transit and storage
Process verification Sterilization records, biological and chemical indicator results supplied with each load

Failure notification Contractual duty to notify the facility immediately of any process failure affecting delivered devices

Recall support Ability to identify which facility devices were in an affected load
Loaner and consignment instruments

Loaner trays are a recurring failure point: they arrive late, are unfamiliar, come with missing or generic IFUs, and are sometimes labeled "sterile" by a vendor whose process the facility has never verified.

Policy should require:

Arrival lead time sufficient for full decontamination and sterilization — commonly at least two business days before the case

Decontamination and sterilization on arrival regardless of labeling , because the facility cannot verify an outside process

Complete, device-specific IFUs delivered with the tray
Inventory verification and inspection against a count sheet on receipt and return
No direct-to-OR delivery bypassing sterile processing
Immediate Use Steam Sterilization (IUSS)

Formerly called "flash sterilization," IUSS processes an unwrapped or containerized item for immediate use with no storage.

Acceptable Not acceptable

A single instrument dropped during a procedure with no replacement available Routine processing because inventory is inadequate

A genuinely emergent, unanticipated need Convenience or to shorten turnover time

Implantable devices — except in a documented emergency, and then only with a rapid-readout biological indicator and full documentation

Every IUSS cycle must be documented with the item, the reason, the cycle parameters, the patient, and the monitoring results. A rising IUSS rate is an inventory problem, a scheduling problem, or a workflow problem — and it is one of the most informative metrics an IP can trend in the perioperative environment.